Pharma ETFs Down Post Q3 Earnings

The string of earnings beat failed to boost pharma ETFs as they saw rough trading over the past one month.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.